Target Information
Yeasty is a pioneering foodtech startup that provides food manufacturers with an alternative protein source derived from unused brewer's yeast. Recently, the company secured €1.4 million in a financing round led by Asterion Ventures, with additional participation from Satgana and Caméléon Invest. The investment attracted over 40 business angels, including prominent figures such as Cédric Sellin, Clément Alteresco of Morning Coworking, and Anne Carole Coen from Swile. Yeasty is further supported by industry expert Alexis Angot from Ynsect, who serves as a Board Member.
Yeasty addresses a critical issue facing brewers and food manufacturers. For brewers, it provides a means to leverage a previously unused raw material, reducing both environmental impact and economic waste. For food manufacturers, Yeasty offers a unique opportunity to access a high-quality protein source that can enhance their product offerings.
Industry Overview
The alternative protein market globally is experiencing rapid growth, driven by rising consumer demand for sustainable and healthier food options. Within this sector, Yeasty stands out with its innovative approach to harnessing brewers' yeast. Research indicates that the global market for protein ingredients, particularly for human applications, is expected to reach $63 billion by 2026, representing an annual growth rate of nearly 9% from 2020 to 2026.
This growth is indicative of evolving consumer preferences towards plant-based and alternative protein sources. Yeasty's product targets a variety of segments, including vegetarian and flexitarian diets, sports nutrition, health and nutrition areas, and various baked goods, promoting sustainability while catering to diverse dietary needs.
In France, the foodtech landscape is burgeoning, with numerous startups committed to innovative approaches within the alternative protein domain. Yeasty’s emphasis on sustainability and nutrition resonates with a growing segment of environmentally-conscious consumers and businesses, marking it as a noteworthy player in this field.
The increasing recognition of the circular economy principles also aligns with Yeasty's mission. By transforming unused brewer's yeast into valuable protein ingredients, the company exemplifies a practical application of these principles, supporting both ecological sustainability and economic viability.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
The recent funding round is a strategic move for Yeasty, enabling the company to industrialize its production process. This will facilitate the development of samples for food manufacturers to experiment with innovative recipes, such as meat alternatives, pasta, high-protein biscuits, and sports nutrition products. The objective for 2025 includes establishing a manufacturing facility with an annual capacity of 5,000 tons, positioning Yeasty for scalable growth within the expanding alternative protein market.
By addressing both production efficiency and nutritional quality, Yeasty is poised to capitalize on the growing consumer preferences for plant-based alternatives, thereby continuing its mission of democratizing access to alternative protein sources that are sustainable and nutritionally superior.
Investor Information
Asterion Ventures led the financing round, underlining its commitment to supporting innovative startups within the foodtech industry. Additionally, the participation of Satgana and Caméléon Invest highlights the investor community’s interest in driving impact-driven businesses that align with sustainable development goals.
Investors are recognizing the significant potential inherent in companies like Yeasty that challenge traditional food production paradigms. By supporting Yeasty, they are backing a startup that not only promises financial returns but also contributes positively to environmental sustainability and public health through innovative food solutions.
View of Dealert
The investment in Yeasty seems to be a sound decision, given the increasing shift towards alternative protein sources in the food industry. With strong market growth projections and innovative product offerings, Yeasty is well-positioned to capture market share and drive revenue. The uniqueness of their product, derived from unused brewer's yeast and devoid of bitterness, provides a competitive edge that can attract a diverse range of food manufacturers.
Moreover, the company's dedication to the principles of the circular economy aligns well with current consumer preferences for sustainable product sourcing. By transforming underutilized resources into high-quality protein, Yeasty not only enhances food production efficiency but also supports environmental conservation efforts.
Additionally, the extensive backing from notable investors and business angels adds credibility to Yeasty's mission and operational capacity, suggesting confidence in the company's future prospects. As the demand for alternative proteins continues to surge, Yeasty's proactive approach to production scaling and market entry is likely to yield favorable outcomes.
In conclusion, with a clear growth strategy and a unique product offering, Yeasty represents a promising investment opportunity within the expanding alternative protein sector. Should the company meet its production and market goals, it has the potential to emerge as a leader in the industry.
Similar Deals
FPCI Food Invest, Elevation Capital Partners, UI Investissement → Amoseeds
2023
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
Fonds Ile-de-France Réindustrialisation → HiQuTe Diamond
2025
Fonds Ile-de-France Réindustrialisation, French Tech Seed, TF Participations, Socadif, iXcore → HiQuTe Diamond
2025
Asterion Ventures
invested in
Yeasty
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $1M